151 related articles for article (PubMed ID: 37972710)
1. Use of 2% taurolidine lock solution for treatment and prevention of catheter-related bloodstream infections in neonates: a feasibility study.
Savarese I; Yazami S; De Rose DU; Carkeek K; Campi F; Auriti C; Danhaive O; Piersigilli F
J Hosp Infect; 2024 Jan; 143():76-81. PubMed ID: 37972710
[TBL] [Abstract][Full Text] [Related]
2. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
3. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
[No Abstract] [Full Text] [Related]
4. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
[TBL] [Abstract][Full Text] [Related]
5. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
Neusser MA; Bobe I; Hammermeister A; Wittmann U
Br J Nurs; 2021 Jul; 30(14):S24-S32. PubMed ID: 34288746
[TBL] [Abstract][Full Text] [Related]
6. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
Klek S; Szczepanek K; Hermanowicz A; Galas A
JPEN J Parenter Enteral Nutr; 2015 Mar; 39(3):331-5. PubMed ID: 24604029
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
[TBL] [Abstract][Full Text] [Related]
8. Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis.
Sun Y; Wan G; Liang L
PLoS One; 2020; 15(4):e0231110. PubMed ID: 32255798
[TBL] [Abstract][Full Text] [Related]
9. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
Demirok A; Illy DHC; Nagelkerke SQ; Lagerweij MF; Benninga MA; Tabbers MM
JPEN J Parenter Enteral Nutr; 2024 May; 48(4):486-494. PubMed ID: 38605559
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
Al-Amin AH; Sarveswaran J; Wood JM; Burke DA; Donnellan CF
J Vasc Access; 2013; 14(4):379-82. PubMed ID: 23817948
[TBL] [Abstract][Full Text] [Related]
11. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Chu HP; Brind J; Tomar R; Hill S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):403-7. PubMed ID: 22595973
[TBL] [Abstract][Full Text] [Related]
12. [Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital].
Jordán P M; Haro C; Puchi A
Rev Chilena Infectol; 2021 Feb; 38(1):15-21. PubMed ID: 33844787
[TBL] [Abstract][Full Text] [Related]
13. [Taurolidine, an antiseptic for the prevention of central venous catheter-related infections].
Haro C
Rev Chilena Infectol; 2019 Aug; 36(4):414-420. PubMed ID: 31859763
[TBL] [Abstract][Full Text] [Related]
14. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
Handrup MM; Møller JK; Schrøder H
Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
[TBL] [Abstract][Full Text] [Related]
15. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Agarwal AK; Roy-Chaudhury P; Mounts P; Hurlburt E; Pfaffle A; Poggio EC
Clin J Am Soc Nephrol; 2023 Nov; 18(11):1446-1455. PubMed ID: 37678222
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
Wouters Y; Roosenboom B; Causevic E; Kievit W; Groenewoud H; Wanten GJA
Clin Nutr; 2019 Oct; 38(5):2210-2218. PubMed ID: 30292482
[TBL] [Abstract][Full Text] [Related]
17. Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
Brescia F; Pittiruti M; Scoppettuolo G; Zanier C; Nadalini E; Bottos P; Moreal C; Da Ros V; Fabiani F
J Vasc Access; 2023 Jan; 24(1):87-91. PubMed ID: 34148394
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.
Vernon-Roberts A; Lopez RN; Frampton CM; Day AS
JPEN J Parenter Enteral Nutr; 2022 Sep; 46(7):1535-1552. PubMed ID: 35233792
[TBL] [Abstract][Full Text] [Related]
19. Mechanical Complications in Central Lines Using Taurolidine Versus Ethanol Lock Therapy in Children With Intestinal Failure.
Strauss J; Boctor DL; Silverman JA; Casey L
J Pediatr Gastroenterol Nutr; 2022 Jun; 74(6):776-781. PubMed ID: 35213858
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]